Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (41-50 of 365) with videos related to

Pageof 37
Sort By:
Cancer Investigation|January 1, 1990
Toremifene as an anticancer agentV C Jordan
Molecular and Cellular Endocrinology|December 21, 1990
"The only true antiestrogen is no estrogen"V C Jordan
Journal of the National Cancer Institute|November 7, 1990
Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifenV C Jordan
Breast Cancer Research and Treatment|May 1, 1990
Long-term adjuvant tamoxifen therapy for breast cancerV C Jordan
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Molecular biology of the estrogen receptor aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifeneV C Jordan
Annual Review of Pharmacology and Toxicology|January 1, 1995
Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancerV C Jordan
Cancer Treatment Reports|October 1, 1976
Antiestrogenic and antitumor properties of tamoxifen in laboratory animalsV C Jordan
Annals of the New York Academy of Sciences|September 30, 1995
An overview of considerations for the testing of tamoxifen as a preventive for breast cancerV C Jordan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1995
Tamoxifen for breast cancer preventionV C Jordan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
What if tamoxifen (ICI 46,474) had been found to produce rat liver tumors in 1973? A personal perspectiveV C Jordan
Pageof 37

Showing results (41-50 of 365) with videos related to

Sort By:
Pageof 37
Cancer Investigation|January 1, 1990
Toremifene as an anticancer agentV C Jordan
Molecular and Cellular Endocrinology|December 21, 1990
"The only true antiestrogen is no estrogen"V C Jordan
Journal of the National Cancer Institute|November 7, 1990
Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifenV C Jordan
Breast Cancer Research and Treatment|May 1, 1990
Long-term adjuvant tamoxifen therapy for breast cancerV C Jordan
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Molecular biology of the estrogen receptor aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifeneV C Jordan
Annual Review of Pharmacology and Toxicology|January 1, 1995
Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancerV C Jordan
Cancer Treatment Reports|October 1, 1976
Antiestrogenic and antitumor properties of tamoxifen in laboratory animalsV C Jordan
Annals of the New York Academy of Sciences|September 30, 1995
An overview of considerations for the testing of tamoxifen as a preventive for breast cancerV C Jordan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1995
Tamoxifen for breast cancer preventionV C Jordan
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
What if tamoxifen (ICI 46,474) had been found to produce rat liver tumors in 1973? A personal perspectiveV C Jordan
Pageof 37